Literature DB >> 3684281

Effect of defocus on visual field measurement.

D A Atchison1.   

Abstract

Defocus increased visual field contrast thresholds for stimuli equal to or smaller than Goldmann perimeter target III (26 min arc diameter). Beyond 30 degrees-40 degrees from the centre of the visual field, defocus had little effect on contrast thresholds. For accurate clinical perimetry, ametropia and presbyopia should be corrected for small targets (less than or equal to target III) within 30 degrees-40 degrees of fixation with either a spectacle lens (if required power less than +/- 10 D) or a contact lens. Larger stimuli are little affected by defocus. Outside this central 30 degrees-40 degrees field, correction with contact lenses should be provided if fixation is poor due to ametropia. Scotomata for which no cause is evident should be further investigated to find whether they have a refractive basis.

Entities:  

Mesh:

Year:  1987        PMID: 3684281

Source DB:  PubMed          Journal:  Ophthalmic Physiol Opt        ISSN: 0275-5408            Impact factor:   3.117


  5 in total

1.  The influence of stimulus parameters on the visual field indices by automated projection perimetry.

Authors:  M Dengler-Harles; J M Wild; M D Cole; E C O'Neill
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-06       Impact factor: 3.117

2.  Peripheral aberrations and image quality for contact lens correction.

Authors:  Jie Shen; Larry N Thibos
Journal:  Optom Vis Sci       Date:  2011-10       Impact factor: 1.973

3.  Blur-resistant perimetric stimuli.

Authors:  Douglas G Horner; Mitchell W Dul; William H Swanson; Tiffany Liu; Irene Tran
Journal:  Optom Vis Sci       Date:  2013-05       Impact factor: 1.973

4.  Influence of uncorrected ametropia on computer-based perimetry in patients with visual field defects and normal subjects.

Authors:  Sandra Jobke; Erich Kasten; Bernhard A Sabel
Journal:  Clin Ophthalmol       Date:  2007-06

5.  Optimizing contrast sensitivity perimetry for clinical use.

Authors:  Mitchell W Dul
Journal:  J Ophthalmic Vis Res       Date:  2013-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.